Thermo Fisher Scientific Plans Senior Note Offering

Hits:1490   Date: 11/16/2009

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific plans to offer its 2.5 percent senior convertible notes in an effort to raise funding to refinance some of its outstanding debts, the company said today.

The life sciences and biotech firm intends to offer the 2.5 percent senior notes, due 2023, of which $295.4 million aggregate principal amount is outstanding as of November 12, 2009, in a private placement to qualified institutional investors.

The company also plans to redeem its 6.75 percent senior subordinated notes due 2014, of which $300 million in aggregate principal is outstanding.